Ayrton Capital LLC 13D/13G Filings for Enveric Biosciences, Inc. (ENVB)

Ayrton Capital LLC 13D and 13G filings for Enveric Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-13
3:42 pm
Sale
2025-09-3013GENVERIC BIOSCIENCES INC OC
ENVB
Ayrton Capital LLC658,465
9.990%
-8,497decrease
(-1.27%)
Filing